Stroke and Molecular Imaging: a Focus on FDG-PET
Overview
Authors
Affiliations
Stroke is the leading cause of disability worldwide, the second most common cause of dementia and the third leading cause of death. Though the etiology of stroke has been explored extensively, there remains open questions in the scientific and clinical study of stroke. Traditional imaging techniques, such as magnetic resonance imaging and computed tomography, have been applied extensively and remain mainstays in clinical practice. Nevertheless, positron emission tomography has proven to be a powerful molecular imaging tool in exploring the scientific aspects of neurological disease, and stroke remains an area of great interest. This review article examines the role of positron emission tomography in the study of stroke including its contributions to elaborating related pathophysiology and delving into possible clinical applications.
Goette A, Corradi D, Dobrev D, Aguinaga L, Cabrera J, Chugh S Europace. 2024; 26(9).
PMID: 39077825 PMC: 11431804. DOI: 10.1093/europace/euae204.
Noninvasive PET imaging of tumor PD-L1 expression with Cu-labeled Durvalumab.
Malih S, Lin W, Tang Z, DeLuca M, Engle J, Alirezapour B Am J Nucl Med Mol Imaging. 2024; 14(1):31-40.
PMID: 38500749 PMC: 10944374.